Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129061) titled 'Comparative efficacy and safety of polymyxin alone and polymyxin plus tigecycline for Carbapenem-resistant Klebsiella pneumoniae infections: a retrospective cohort study' on July 30.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Shandong Provincial Hospital
Condition:
Carbapenem-resistant Klebsiella pneumoniae infections
Intervention:
Polymyxin combination therapy group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-08-03
Target Sample Size: Polymyxin combination therapy group:50;Polymyxin monotherapy group:50;
Countries of Recruitmen...